Skip to main content

Lauren Mateja, Managing Editor

Lauren Mateja, Managing Editor
Women have found an increasing presence throughout dermatology both at a general and subspecialty level, but gaps in representation remain.
Lauren Mateja, Managing Editor
Atopic dermatitis is a chronic disease requiring long-term monitoring of symptoms and triggers. Patients can proactively monitor their eczema with a new, easy-to-use mobile app.
Lauren Mateja, Managing Editor
While a number of new therapeutic agents have been approved to treat the signs of rosacea, much needed research is underway to better understand its pathogenesis.
Lauren Mateja, Managing Editor
As a largely misunderstood and misdiagnosed disease, hidradenitis suppurativa is beginning to come to the forefront of dermatologic research.
Lauren Mateja, Managing Editor
The dearth of clinical images of the cutaneous manifestations of COVID-19 in higher Fitzpatrick skin types represents a larger problem: how can dermatology diagnose diseases in darker skin if clinicians do not know what to look for?
Lauren Mateja, Managing Editor
A recent survey by the National Rosacea Society revealed that while patients were satisfied with their current therapies, older patients were more likely to use older treatments, signaling a need to revisit management plans.
Lauren Mateja, Managing Editor
As research continues to better differentiate between eczema and other diagnoses, the National Eczema Association continues to push awareness among patients and physicians with Eczema Awareness Month.
Lauren Mateja, Managing Editor
Continuing education is critical to improving your practice and, ultimately, patient care. Preview the latest offerings in continuing medical education, from virtual meetings to currently scheduled live conferences.
Lauren Mateja, Managing Editor
Lynn McKinley-Grant, MD, FAAD details what you need to remember when diagnosing and treating psoriasis in patients of color.
Lauren Mateja, Managing Editor
Treating psoriasis in our pediatric patients is generally similar to treating psoriasis in adults, but the psychosocial burden on the patient and their caregivers should be a point of emphasis in the visits and approach to management.
Back to Top